Chesapeake Urology Associates Physicians Named to the Super Doctors® 2012 List
BALTIMORE, Nov. 19, 2012 /PRNewswire/ — For the second consecutive year, four urologists from Chesapeake Urology Associates, PA have been named to the Super Doctors® 2012 List for the Maryland/Washington, D.C., area. These physicians are among just five percent in the region to be honored with inclusion on the Super Doctors 2012 List.
Each year, Key Professional Media undertakes a rigorous multi-phase selection process that includes a survey of doctors, independent evaluation of candidates by the research staff, a peer review of candidates by practice area and a good-standing and disciplinary check. As a part of this evaluation, physicians are asked to consider what doctors in the area they would choose for their own care. The awards come on the heels of six urologists and two urologic oncologists from Chesapeake Urology Associates being named to the prestigious Top Docs list by Baltimore Magazine.
“With these consistent honors by our peers, we are proud to acknowledge the hard work and dedication of our physicians,” says Sanford J. Siegel, M.D., president and CEO of Chesapeake Urology Associates. “Our patients can take comfort in knowing that our physicians provide the best care available in this region of the country.”
The award recipients include:
Daniel D. Dietrick, M.D., F.A.C.S., holds the position of chief of surgery at St. Joseph Medical Center. Dr. Dietrick specializes in prostate cancer, including daVinci robotic prostate surgery, medical and minimally invasive treatment of enlarged prostate (BPH), voiding problems in men, and no-scalpel vasectomy. He is certified by the American Board of Urology and is a member of the American College of Physician Executives.
Brad D. Lerner, M.D., F.A.C.S., serves as clinical director of Chesapeake Urology’s Summit Ambulatory Surgical Centers, as co-director of the Reproductive Medicine, Microsurgery and Sexuality program, and as the co-director of the Vasectomy Reversal Center of America. In addition, Dr. Lerner is chief of urology at Union Memorial Hospital and the urologic consultant to the NFL Baltimore Ravens. Dr. Lerner‘s specific clinical interests include vasectomy and vasectomy reversal, sperm retrieval procedures and male infertility. He is one of the leading male fertility and microsurgical vasectomy reversal specialists in the mid-Atlantic region. Dr. Lerner is certified by the American Board of Urology.
Marc H. Siegelbaum, M.D., F.A.C.S., is the director of Chesapeake Urology’s Erectile Dysfunction program and is also the urological consultant to the Baltimore Orioles. He practices general urology and is a specialist in robotic prostate surgery, laparoscopic kidney surgery and penile and incontinence prosthetics. Dr. Siegelbaum is chief of urology and medical director of the Urologic Oncology Institute at St. Joseph Medical Center. He is certified by the American Board of Urology.
Ronald F. Tutrone, M.D., F.A.C.S., serves as medical director of Chesapeake Urology Research Associates, and chief of urology at the Greater Baltimore Medical Center. Dr. Tutrone is certified by the American Board of Urology and specializes in urologic malignancies, laparoscopic treatment of renal and adrenal tumors, kidney stones, urinary incontinence and prostate disorders. In addition, he is chairman of the William E. Kalhert Endowment for Urological Research at the Greater Baltimore Medical Center.
Chesapeake Urology Associates is the premier urology practice in Maryland and the Mid-Atlantic region. CUA’s urologists deliver the most innovative and compassionate urology care available. Composed of more than 45 of the region’s top urologists, including many who are fellowship trained, 4 radiation oncologists, and a urologic pathologist, Chesapeake Urology provides the convenience of 16 urology centers and 15 AAAHC-certified surgical centers throughout the greater Baltimore, Maryland area. CUA’s experienced, board-certified urologists use advanced treatments to manage all types of urological problems for adults and children including urologic cancers (prostate, bladder, kidney, penile and testicle), enlarged prostate, kidney stones, urinary incontinence, urinary tract infections, hematuria, erectile dysfunction, male infertility and sexual health, vasectomy and vasectomy reversal, pelvic pain and clinical trials for urologic conditions. For information about Chesapeake Urology, please visit www.ChesapeakeUrology.com.
SOURCE Chesapeake Urology Associates